These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38794964)

  • 1. TRPS1 function beyond breast: A retrospective immunohistochemical study on non-breast cytology specimens.
    Ali A; Geetha S; Wu D; Chau K; Karam P; Khutti S; Fayyaz SS; Das K; Gimenez C; Rosca OC
    Diagn Cytopathol; 2024 Sep; 52(9):499-504. PubMed ID: 38794964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
    Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPS1 outperforms GATA3 in pleural effusions with metastatic breast carcinoma versus mesothelioma.
    Baban F; Koepplin JW; Ahmad M; Clarke-Brodber AL; Bois MC; Hartley CP; Sturgis CD
    Diagn Cytopathol; 2023 Aug; 51(8):488-492. PubMed ID: 37096814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma.
    Wang M; Stendahl K; Cai G; Adeniran A; Harigopal M; Gilani SM
    Am J Clin Pathol; 2022 Sep; 158(3):416-425. PubMed ID: 35760555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens.
    Donthi D; Gan Q; Ding QQ; Krishnamurthy S
    Cancer Cytopathol; 2024 Dec; 132(12):799-808. PubMed ID: 39264831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Chen CJ; Hang JF; Chen YA; Lin SJ; Chiu HM; Hsu CY; Lai CR; Yang CS
    Cancer Cytopathol; 2023 Apr; 131(4):226-233. PubMed ID: 36399408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples.
    Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F
    Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumors.
    Rammal R; Goel K; Elishaev E; Soong TR; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Skvarca L; Harinath L; Bhargava R
    Am J Clin Pathol; 2023 Oct; 160(4):425-434. PubMed ID: 37352847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of TRPS1 in Malignant Effusion Cytology.
    Tjendra Y; Millan N; Velez Torres JM; Zuo Y; Garcia-Buitrago M; Jorda M; Gomez-Fernandez CR
    Acta Cytol; 2023; 67(3):273-279. PubMed ID: 36634642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma.
    Bradt A; Jing X; Smola BS; Lew M
    Diagn Cytopathol; 2023 Nov; 51(11):665-673. PubMed ID: 37461248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Bachert SE; Di J; Zhang S; Short HE; Piecoro DW; McDonald RJ; Myint ZW; Hensley PJ; Allison DB
    Hum Pathol; 2024 Jan; 143():42-49. PubMed ID: 38052269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPS1, a sensitive marker for different histological and molecular types of breast cancer.
    Kong C; Yu B; Bi R; Xu X; Cheng Y; Yang W; Shui R
    Diagn Pathol; 2024 Sep; 19(1):121. PubMed ID: 39243111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichorhinophalangeal syndrome type 1 (TRPS1) expression in male breast carcinoma.
    Law T; Piotrowski MJ; Ning J; Jiang X; Ding Q; Sahin AA
    Hum Pathol; 2023 Aug; 138():62-67. PubMed ID: 37331526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study: Comparison of TRPS1 and GATA3 immunoperoxidase staining using cytologic smears in entities reportedly positive for GATA3.
    Rohra P; Ding C; Yoon EC; Gan Q
    Cancer Cytopathol; 2022 Dec; 130(12):930-938. PubMed ID: 35790088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics.
    Cho WC; Ding Q; Wang WL; Nagarajan P; Curry JL; Torres-Cabala CA; Ivan D; Albarracin CT; Sahin A; Prieto VG; Aung PP
    J Cutan Pathol; 2023 May; 50(5):434-440. PubMed ID: 36808637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
    Parkinson B; Chen W; Shen T; Parwani AV; Li Z
    Am J Surg Pathol; 2022 Mar; 46(3):415-423. PubMed ID: 35175968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens.
    Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z
    Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.